MoH Approves Sotrovimab COVID-19 Treatment

The Ministry of Health (MoH) declared on Wednesday issuing licenses for emergency use of the medicine Sotrovimab (7831-VIR) for treating light and medium coronavirus cases.

Dr. Abdullah Al-Badr, the assistant undersecretary for medicines and nutrition supervision, told KUNA the drug is used for such cases among adults and children aged 12 and above.

He has indicated that the medicine is used for persons of 65 years of age and above, but not for hospitalized patients who need oxygen due to infection with COVID-19. Clinical studies have shown that this medicine has lowered hospital admissions and deaths by 85 percent. It prevents the virus from sneaking into human cells.



Related Articles

Leave a Reply

Your email address will not be published.

Back to top button

Adblock Detected

Support us by allowing our Ads to show on our website!